BIO-key International Inc. (NASDAQ:BKYI) Sees Significant Decrease in Short Interest

BIO-key International Inc. (NASDAQ:BKYI) saw a significant decrease in short interest in February. As of February 13th, there was short interest totaling 310,850 shares, a decrease of 75.8% from the January 29th total of 1,284,522 shares. Based on an average daily volume of 357,109 shares, the short-interest ratio is presently 0.9 days. Approximately 3.0% of the shares of the stock are sold short. Approximately 3.0% of the shares of the stock are sold short. Based on an average daily volume of 357,109 shares, the short-interest ratio is presently 0.9 days.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the company. Wall Street Zen raised BIO-key International to a “sell” rating in a research note on Saturday, January 3rd. Weiss Ratings reiterated a “sell (e+)” rating on shares of BIO-key International in a research report on Wednesday, January 21st. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

BIO-key International Trading Up 2.4%

BIO-key International stock traded up $0.02 during trading on Friday, reaching $0.65. The company had a trading volume of 163,050 shares, compared to its average volume of 468,441. BIO-key International has a 12-month low of $0.51 and a 12-month high of $1.97. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.13 and a current ratio of 1.26. The stock’s 50 day moving average price is $0.61 and its two-hundred day moving average price is $0.72. The firm has a market capitalization of $7.09 million, a price-to-earnings ratio of -0.63 and a beta of 0.41.

Institutional Investors Weigh In On BIO-key International

An institutional investor recently raised its position in BIO-key International stock. Geode Capital Management LLC grew its position in shares of BIO-key International Inc. (NASDAQ:BKYI) by 49.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 48,892 shares of the technology company’s stock after purchasing an additional 16,271 shares during the period. Geode Capital Management LLC owned approximately 0.45% of BIO-key International worth $26,000 as of its most recent SEC filing. Institutional investors own 26.51% of the company’s stock.

BIO-key International Company Profile

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.